Product Description: Iclaprim is a new selective bacterial Dihydrofolate inhibitor, which can inhibit the growth of S. aureus (MRSA) with an MIC90 of 0.06 μg/mL.
Applications: COVID-19-immunoregulation
Formula: C19H22N4O3
References: [1]Schneider P, et al. Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria. Bioorg Med Chem Lett. 2003 Dec 1;13(23):4217-21./[2]Kohlhoff SA, et al. Iclaprim. Expert Opin Investig Drugs. 2007 Sep;16(9):1441-8.
CAS Number: 192314-93-5
Molecular Weight: 354.40
Compound Purity: 99.49
Research Area: Infection
Solubility: DMSO : 30 mg/mL (ultrasonic;warming)
Target: Antibiotic;Bacterial